Novo Nordisk A/S company logo
Novo Nordisk A/S logo

Novo Nordisk A/S (NVO) Cash and Cash Equivalents

Annual Cash & Cash Equivalents

$3.65B$826.54M-18.45%

Summary

Current Value
As of today, NVO annual cash & cash equivalents is $3.65B, down -18.45% on
Historical Performance
NVO annual cash & cash equivalents is up +36.64% over the past 3 years, and up +57.15% over the past 5 years
All-Time High Comparison
NVO annual cash & cash equivalents is currently -18.45% below its historical high of $4.48B set on
3-Year Low Comparison
NVO annual cash & cash equivalents is +7.98% above its 3-year low of $3.38B reached on an earlier date
Sector Comparison
NVO annual cash & cash equivalents is higher than 97.37% of companies in Healthcare sector

Cash and Cash Equivalents Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

NVO Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash & Cash Equivalents$3.65B-18.4%+36.6%+57.1%
Quarterly Cash & Cash Equivalents$5.13B-54.3%+3.9%+27.8%+115.5%
Price$62.09-22.9%-12.0%+70.5%+457.4%
Annual Current Assets$22.34B+8.0%+70.7%+138.1%+254.7%
Annual Total Liabilities$44.76B+45.3%+136.5%+338.0%+1222.3%
Annual Working Capital-$7.86B-76.8%-269.4%-1607.3%-311.9%
Annual Net Income$14.65B+20.6%+93.0%+150.8%+628.4%

Cash and Cash Equivalents Highs

NVO Annual Cash & Cash Equivalents Highs Comparison
PeriodHighDateCurrent
3Y$4.48B-18.4%
5Y$4.48B-18.4%
All$4.48B-18.4%

Cash and Cash Equivalents Lows

NVO Annual Cash & Cash Equivalents Lows Comparison
PeriodLowDateCurrent
3Y$3.38BN/A+8.0%
5Y$2.10BN/A+74.2%
All$42.25M+8547.1%

Cash and Cash Equivalents History

YearValueChange
$3.65B-18.5%
$4.48B+32.4%
$3.38B+26.6%
$2.67B+27.5%
$2.10B-9.8%
$2.32B-3.0%
$2.40B-29.8%
$3.41B+13.3%
$3.01B-0.4%
$3.02B+16.8%
$2.59B-12.3%
$2.95B-1.9%
$3.01B-1.8%
$3.07B+6.1%
$2.89B+1,076.8%
$245.54M-59.6%
$608.00M+42.4%
$426.90M-27.7%
YearValueChange
$590.30M+24.4%
$474.66M-29.4%
$672.50M+0.7%
$667.98M+27.3%
$524.63M-15.8%
$623.29M-15.7%
$739.57M+43.6%
$514.85M+15.1%
$447.28M+22.3%
$365.59M+9.5%
$334.00M+23.1%
$271.22M+15.5%
$234.86M+23.8%
$189.65M+6.1%
$178.78M+107.3%
$86.25M-20.2%
$108.06M+155.8%
$42.25M-

FAQ

  • What is the current annual cash & cash equivalents of NVO?

    As of today, NVO annual cash & cash equivalents is $3.65B

  • What is 1-year change in NVO annual cash & cash equivalents?

    NVO annual cash & cash equivalents is down -18.45% year-over-year

  • What is 3-year change in NVO annual cash & cash equivalents?

    NVO annual cash & cash equivalents is up +36.64% over the past 3 years

  • How far is NVO annual cash & cash equivalents from its all-time high?

    NVO annual cash & cash equivalents is currently -18.45% below its historical high of $4.48B set on December 31, 2023

  • How does NVO annual cash & cash equivalents rank versus sector peers?

    NVO annual cash & cash equivalents is higher than 97.37% of companies in Healthcare sector

  • When is NVO next annual earnings release?

    The next annual earnings release for NVO is on

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

  1. NVO Official Website www.novonordisk.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/353278/000035327825000005/0000353278-25-000005-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/353278/000162828025003920/0001628280-25-003920-index.htm
  4. NVO Profile on Yahoo Finance finance.yahoo.com/quote/NVO
  5. NVO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvo